Patents by Inventor Lorraine B. Peddada

Lorraine B. Peddada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8158341
    Abstract: A method is provided for identifying viral positive biological fluid donations in the fewest number of test cycles. The method comprises providing biological fluid donations and defining an n-dimensional matrix comprising a multiplicity of elements, each element being identified by a matrix notation comprising an index for each dimension of the array. Samples are taken from each fluid donation and mapped to a matrix element with each sample identified by its corresponding element's notation; n aliquots being taken from each sample and subpools formed from the aliquots with each subpool containing an aliquot from all samples mapped to elements in which one of the dimensional indices is fixed. Subpools are tested for viral indication and the dimensional index of each subpool that returns a positive viral indication is determined. The dimensional indices are combined to identify a subset of matrix elements that contain a viral positive sample.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: April 17, 2012
    Assignee: Baxter International Inc.
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad, Peter Schmid
  • Publication number: 20090263788
    Abstract: Systems, processes, and devices are provided which are useful for testing blood or plasma donations to detect those specific donations which are contaminated by a virus above a predetermined level. Samples are formed into pools which are subsequently tested for virus contamination by a high-sensitivity test such as PCR. The pools are tested in accordance with an algorithm by which a sample from each donation is mapped to each element of an N-dimensional matrix or grid. Each element of the matrix is identified by a matrix identifier, Xrcs, where rcs defines the dimensional index. An aliquot is taken from each sample, and subpools are formed, each subpool comprising aliquots of samples in which one dimensional index is fixed. All of the subpools are tested in one PCR test cycle.
    Type: Application
    Filed: June 29, 2009
    Publication date: October 22, 2009
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad, Peter Schmid
  • Publication number: 20030204321
    Abstract: Systems, processes, and devices are provided which are useful for testing blood or plasma donations to detect those specific donations which are contaminated by a virus above a predetermined level. An apparatus and process is described which forms individual, separately sealed and connected sample containers from a flexible hollow tubing segment connected to a fluid donation container. The tubing segment is sealed at spaced-apart intervals along its length, with tubing segment portions in the intervals between the seals defining containers, each of which holds a portion of a plasma sample. The contents of the containers are formed into pools which are subsequently tested for virus contamination by a high-sensitivity test such as PCR. The pools are tested in accordance with an algorithm by which a sample from each donation is mapped to each element of an N-dimensional matrix or grid. Each element of the matrix is identified by a matrix identifier, Xrcs, where rcs defines the dimensional index.
    Type: Application
    Filed: May 20, 2003
    Publication date: October 30, 2003
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad, Peter Schmid
  • Patent number: 6566052
    Abstract: Systems, processes, and devices are provided which are useful for testing blood or plasma donations to detect those specific donations which are contaminated by a virus above a predetermined level. An apparatus and process is described which forms individual, separately sealed and connected sample containers from a flexible hollow tubing segment connected to a fluid donation container. The tubing segment is sealed at spaced-apart intervals along its length, with tubing segment portions in the intervals between the seals defining containers, each of which holds a portion of a plasma sample. The contents of the containers are formed into pools which are subsequently tested for virus contamination by a high-sensitivity test such as PCR. The pools are tested in accordance with an algorithm by which a sample from each donation is mapped to each element of an N-dimensional matrix or grid. Each element of the matrix is identified by a matrix identifier, Xrcs, where rcs defines the dimensional index.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: May 20, 2003
    Assignee: Alpha Therapeutic Corporation
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad, Peter Schmid
  • Patent number: 6348336
    Abstract: A process is provided for preparing samples of blood, blood plasma, blood serum, or plasma proteins, including blood factor products, for PCR testing which minimizes contaminants which may interfere with the analysis. The process includes centrifugation of the initial sample to form a sample pellet, removing at least a portion of the supernatant from the pellet, and washing the pellet with an aqueous buffer. The buffer and washed pellet are then centrifuged, and a portion of the remaining supernatant is removed along with any contaminants contained therein. The clean, substantially contaminant-free pellet is then processed for PCR analysis.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: February 19, 2002
    Assignee: Alpha Therapeutic Corporation
    Inventors: H. Edward Matveld, Lorraine B. Peddada, Andrew J. Conrad, Charles M. Heldebrant
  • Patent number: 6063563
    Abstract: Systems, processes, and devices are provided which are useful for testing blood or plasma donations to detect those specific donations which are contaminated by a virus above a predetermined level. An apparatus and process is described which forms individual, separately sealed and connected sample containers from a flexible hollow tubing segment connected to a fluid donation container. The tubing segment is sealed at spaced-apart intervals along its length, with tubing segment portions in the intervals between the seals defining containers, each of which holds a portion of a plasma sample. The contents of the containers are formed into pools which are subsequently tested for virus contamination by a high-sensitivity test such as PCR The pools are tested in accordance with an algorithm by which a sample from each donation is mapped to each element of an N-dimensional matrix or grid. Each element of the matrix is identified by a matrix identifier, X.sub.rcs, where rcs defines the dimensional index.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: May 16, 2000
    Assignee: Alpha Therapeutic Corporation
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad
  • Patent number: 5780222
    Abstract: Systems, processes, and devices are provided which are useful for testing blood or plasma donations to detect those specific donations which are contaminated by a virus above a predetermined level. An apparatus and process is described which forms individual, separately sealed and connected sample containers from a flexible hollow tubing segment connected to a fluid donation container. The tubing segment is sealed at spaced-apart intervals along its length, with tubing segment portions in the intervals between the seals defining containers, each of which holds a portion of a plasma sample. The contents of the containers are formed into pools which are subsequently tested for virus contamination by a high-sensitivity test such as PCR. The pools are tested in accordance with an algorithm by which a sample from each donation is mapped to each element of an N-dimensional matrix or grid. Each element of the matrix is identified by a matrix identifier, X.sub.rcs, where rcs defines the dimensional index.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: July 14, 1998
    Assignee: Alpha Therapeutic Corporation
    Inventors: Lorraine B. Peddada, Charles M. Heldebrant, Andrew J. Conrad
  • Patent number: H1960
    Abstract: An automated system and process is provided for pooling samples from a multiplicity of blood or plasma donations for subsequent testing to uniquely identify any such blood or plasma donations which may be infected with a particular virus. The system includes an autosampler needle which is directly inserted into a blood or plasma sample aliquot container in order to withdraw an aliquot portion of the contents for forming a sample pool with aliquot portions of other blood or plasma samples. The autosampler comprises a tubular piercing member having a hollow interior bore and a tubular shroud surrounding the piercing member.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: June 5, 2001
    Assignee: Alpha Therapeutic Corp.
    Inventors: Andrew J. Conrad, Charles M. Heldebrant, Shawn D. Latham, Lorraine B. Peddada